Triglycerides

Why This Matters

Triglycerides are often viewed as little more than stored fat or a marker of dietary excess. They are the body's principal energy reserve and play an essential role in normal metabolism. Although triglycerides themselves are not deposited within atherosclerotic plaques, elevated triglyceride levels frequently indicate an excess of triglyceride-rich ApoB-containing lipoproteins and their cholesterol-rich remnants, both of which contribute to cardiovascular disease. Understanding this distinction is critical for correctly interpreting triglyceride levels in clinical practice.

What Are Triglycerides?

Triglycerides are molecules composed of one glycerol backbone attached to three fatty acids.

They are the body's most efficient form of energy storage because they contain far more energy per gram than carbohydrates or proteins. Triglycerides are stored primarily within adipose tissue and transported through the bloodstream within chylomicrons and VLDL.

Unlike cholesterol, triglycerides are rapidly metabolized and continuously replaced as part of normal energy metabolism.

Sources of Triglycerides

Circulating triglycerides originate from two principal sources.

After meals, dietary triglycerides are packaged into chylomicrons by the intestine. During fasting, the liver synthesizes triglycerides from free fatty acids and, when carbohydrate intake exceeds metabolic needs, through de novo lipogenesis. These triglycerides are exported in VLDL particles to provide energy to peripheral tissues.

Triglyceride Metabolism

Triglycerides cannot enter cells directly.

Lipoprotein lipase hydrolyzes triglycerides within circulating chylomicrons and VLDL, releasing free fatty acids that are taken up by muscle for energy production or by adipose tissue for storage.

As triglycerides are removed, the lipoprotein particles become progressively smaller and proportionally richer in cholesterol, eventually forming remnant lipoproteins and LDL.

Hypertriglyceridemia

Elevated triglycerides most commonly result from increased hepatic VLDL production, impaired clearance of triglyceride-rich lipoproteins, or both.

Insulin resistance plays a central role by increasing free fatty acid delivery to the liver, stimulating hepatic triglyceride synthesis, and promoting excessive VLDL secretion — the mechanistic chain this book's main chapters build the case for the entire book around.

Obesity, type 2 diabetes mellitus, metabolic syndrome, excessive alcohol consumption, chronic kidney disease, hypothyroidism, and certain medications commonly contribute to hypertriglyceridemia.

Triglycerides and Cardiovascular Risk

Triglycerides themselves are not believed to directly cause atherosclerosis because they are rapidly hydrolyzed and are not retained within the arterial wall.

Instead, elevated triglycerides serve as a marker for increased concentrations of triglyceride-rich ApoB-containing lipoproteins and their cholesterol-rich remnants. These particles readily enter the arterial wall and contribute to plaque formation.

The higher the triglyceride concentration, the greater the likelihood that remnant lipoproteins are also elevated, particularly in individuals with insulin resistance.

Triglycerides and Pancreatitis

While moderate hypertriglyceridemia primarily signals increased cardiovascular risk, severe hypertriglyceridemia can precipitate acute pancreatitis.

When triglyceride concentrations become markedly elevated, usually exceeding 500 mg/dL and especially above 1,000 mg/dL, large numbers of chylomicrons accumulate within the circulation. Their metabolism within pancreatic capillaries releases excessive free fatty acids, promoting local inflammation and pancreatic injury. Preventing pancreatitis becomes the immediate therapeutic priority in these patients.

Clinical Relevance

Lifestyle modification — including weight reduction, limiting refined carbohydrates and alcohol, improving insulin sensitivity, and increasing physical activity — remains the cornerstone of therapy for hypertriglyceridemia.

When triglycerides are severely elevated, pharmacologic therapy may be required to reduce the risk of pancreatitis. In patients with mild-to-moderate elevations, treatment should focus on reducing the overall burden of ApoB-containing lipoproteins and correcting the underlying metabolic abnormalities.

Clinical Pearls

• Triglycerides are the body's principal energy storage molecule.
• Chylomicrons and VLDL transport triglycerides through the circulation.
• Elevated triglycerides usually reflect excess triglyceride-rich ApoB-containing lipoproteins.
• Remnant lipoproteins — not triglycerides themselves — are major contributors to atherosclerosis.
• Severe hypertriglyceridemia increases the risk of acute pancreatitis.

Common Misconceptions

Misconception: Triglycerides directly cause atherosclerosis.

Reality: Triglycerides are rapidly metabolized. The associated cholesterol-rich remnant lipoproteins are believed to be the principal atherogenic particles.

Misconception: Elevated triglycerides always result from eating too much fat.

Reality: Insulin resistance, excess carbohydrate intake, hepatic VLDL overproduction, obesity, diabetes, alcohol, and genetic disorders are often more important contributors.

Misconception: Treating triglycerides alone eliminates cardiovascular risk.

Reality: The ultimate therapeutic goal remains reducing lifetime exposure to ApoB-containing lipoproteins while correcting the underlying metabolic disturbances.

Clinical Bottom Line

Triglycerides are essential for normal energy metabolism, but elevated triglyceride levels frequently signal an excess of triglyceride-rich ApoB-containing lipoproteins and their remnants. Understanding the distinction between triglycerides and the particles that carry them is fundamental to assessing cardiovascular risk and selecting appropriate therapy.